Connective Tissue Gene Tests, LLC, commonly referred to as CTGT, is a pioneering company headquartered in the United States, specialising in genetic testing for connective tissue disorders. Founded in 2015, CTGT has rapidly established itself as a leader in the field, focusing on innovative diagnostic solutions that enhance patient care and treatment outcomes. The company offers a range of advanced genetic tests designed to identify mutations associated with various connective tissue diseases. What sets CTGT apart is its commitment to precision and accuracy, utilising cutting-edge technology and a team of expert geneticists. With a strong presence across major operational regions in North America, CTGT has achieved significant milestones, including partnerships with leading healthcare providers and research institutions. This positions the company as a trusted resource in the genetic testing industry, dedicated to improving the lives of those affected by connective tissue disorders.
We don't have data for Connective Tissue Gene Tests, LLC, but we can show you information about their parent organization instead.
View parent company